Related Experiment Video

Updated: Jun 21, 2026

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein
08:18

Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein

Published on: October 4, 2024

Retinoid X receptor heterodimer variants and cardiovascular risk factors

Atsushi Nohara1, Junji Kobayashi, Hiroshi Mabuchi

  • 1Departments of Lipidology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. a-nohara@med.kanazawa-u.ac.jp

Journal of Atherosclerosis and Thrombosis
|August 13, 2009
PubMed

Insights

Human genetic variants of retinoid X receptor (RXR) heterodimers impact metabolic disorders. Understanding these nuclear receptors offers new insights into complex diseases like metabolic syndrome.

Area of Science:

  • Molecular Biology
  • Genetics
  • Endocrinology

Background:

  • Nuclear receptors, activated by ligands, are key transcription factors.
  • Retinoid X receptor (RXR) heterodimers regulate genes in energy homeostasis and atherosclerosis.
  • RXR heterodimers are promising therapeutic targets for metabolic syndrome.

Purpose of the Study:

  • To summarize current understanding of RXR heterodimers using human genetic variants.
  • To explore the role of RXR heterodimers in multifactorial diseases.
  • To provide insights into metabolic syndrome and familial combined hyperlipidemia.

Main Methods:

  • Review of current scientific literature.
  • Analysis of genetic studies on RXR heterodimers.
  • Investigation of human genetic variants impacting metabolic disorders.

Main Results:

  • Genetic variants of RXR heterodimers significantly affect metabolic disorders.
  • Some variants show considerable impact on familial combined hyperlipidemia phenotypes.
  • RXR heterodimers play a crucial role in energy expenditure, lipid and glucose homeostasis, inflammation, and atherosclerosis.

Conclusions:

  • Human genetic variants of RXR heterodimers are critical for understanding metabolic diseases.
  • Further research on RXR heterodimers can uncover the background of multifactorial diseases.
  • Nuclear receptor research provides significant progress in unraveling complex disease control systems.

More Related Videos

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography05:03

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography

Published on: December 27, 2024

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography07:23

Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

Published on: March 26, 2020

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...